A recent study by researchers from Emory's Nell Hodgson Woodruff School of Nursing and Winship Cancer Institute suggests that daily use of the drug tadalafil (Cialis) does not prevent erectile dysfunction for men undergoing radiation therapy for prostate cancer treatment.
Deborah W. Bruner, PhD, RN, FAAN, Woodruff professor of nursing at the Nell Hodgson Woodruff School of Nursing, led the team that evaluated 221 men, 18 years and older with clinical stage II prostate cancer, from 76 medical sites across the United States. Participants were randomly selected to receive either tadalafil or placebo six weeks prior to the start of radiotherapy treatment.